Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial

被引:23
|
作者
Miyazaki, Shougo
Hagihara, Akihito [1 ]
Kanda, Ryo [2 ]
Mukaino, Yoshito [2 ]
Nobutomo, Koichi
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Serv Management & Policy, Higashi Ku, Fukuoka 8128582, Japan
[2] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 81401, Japan
来源
CLINICAL JOURNAL OF PAIN | 2009年 / 25卷 / 05期
关键词
placebo; press needle; double-blind method; low back pain; randomized controlled trial; LOW-BACK-PAIN; NOXIOUS INHIBITORY CONTROLS; ACUPUNCTURE TRIALS; JAPANESE VERSION; ADVERSE EVENTS; OSTEOARTHRITIS; MIGRAINE; KNEE; QUESTIONNAIRE; MOXIBUSTION;
D O I
10.1097/AJP.0b013e318193a6e1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Owing to a lack of a suitable needle procedure, it has been impossible to evaluate the efficacy of acupuncture in clinical studies using double-blind testing. We evaluated the applicability of a new kind of press needle (Pyonex) to a double-blind trial by comparing the press needle with a placebo (lacking the needle element). Methods: The purpose of the study consisted of 2 phases. In the phase 1, to evaluate the applicability and efficacy of the press needles, 90 participants who had never been treated using acupuncture were randomly assigned to receive either the press needle (n = 45) or a placebo (n = 45). The applicability was measured using a questionnaire regarding the perception of penetration, and efficacy was measured using a visual analog scale of low back pain (LBP). When the applicability and efficacy of the press needles were confirmed in phase 1, the mechanism of LBP relief by the press needles was examined in phase 2. Results: In phase 1, intergroup comparisons showed no significant differences concerning the perception of penetration. In addition, for patients with LBP, the press needles reduced the subjective evaluation of LBP compared with the placebo (P < 0.05). In phase 2, visual analog scale results indicated that LBP was reduced significantly more in the press needle group than in the local anesthesia group (P < 0.05). Discussion: The participants could not distinguish between the press needle and a placebo, and the data from the press needle group suggested a specific influence on patients with LBP. These findings imply that the press needle and a placebo provide an effective means of realizing a double-blind setting for clinical studies of acupuncture.
引用
收藏
页码:438 / 444
页数:7
相关论文
共 50 条
  • [21] Double-blind Placebo-controlled Trial of Pleconaril in Infants
    Allan R. Tunkel
    [J]. Current Infectious Disease Reports, 2004, 6 (4) : 295 - 296
  • [22] Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Kawut, Steven M.
    Ellenberg, Susan S.
    Krowka, Michael J.
    Goldberg, David
    Vargas, Hugo
    Koch, David
    Sharkoski, Tiffany
    Al-Naamani, Nadine
    Fox, Alyson
    Brown, Robert
    Levitsky, Joshua
    Oh, Jae K.
    Lin, Grace
    Song, Nianfu
    Mottram, Carl
    Doyle, Margaret F.
    Kaplan, David E.
    Gupta, Samir
    Fallon, Michael B.
    [J]. LIVER TRANSPLANTATION, 2019, 25 (08) : 1155 - 1164
  • [23] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
    Meininger, V
    Asselain, B
    Guillet, P
    Leigh, PN
    Ludolph, A
    Lacomblez, L
    Robberecht, W
    [J]. NEUROLOGY, 2006, 66 (01) : 88 - 92
  • [24] A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania
    Van Ameringen, Michael
    Mancini, Catherine
    Patterson, Beth
    Bennett, Mark
    Oakman, Jonathan
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (10) : 1336 - 1343
  • [25] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
    MURPHY, JJ
    HEPTINSTALL, S
    MITCHELL, JRA
    [J]. LANCET, 1988, 2 (8604): : 189 - 192
  • [26] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF AMITRIPTYLINE IN BULIMIA
    ZITMAN, FG
    VANPUTTEN, PM
    KNOPPERTVANDEKLEIN, EAM
    EDELBROEK, P
    HULSING, M
    VECHTVANDENBERGH, R
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 522 - 522
  • [27] Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy
    Kissel, JT
    McDermott, MP
    Mendell, JR
    King, WM
    Pandya, S
    Griggs, RC
    Tawil, R
    Cos, L
    Langsam, A
    Martens, B
    Brower, C
    Herr, BE
    Figlewicz, D
    Forrester, J
    Downing, K
    Holloway, RG
    Hubble, J
    Kolassa, J
    [J]. NEUROLOGY, 2001, 57 (08) : 1434 - 1440
  • [28] A Double-Blind, Placebo-Controlled, Randomized Trial of Montelukast for Acute Bronchiolitis
    Amirav, Israel
    Luder, Anthony S.
    Kruger, Natalie
    Borovitch, Yael
    Babai, Ilan
    Miron, Dan
    Zuker, Miriam
    Tal, Gay
    Mandelberg, Avigdor
    [J]. PEDIATRICS, 2008, 122 (06) : E1249 - E1255
  • [29] Randomized, double-blind, placebo-controlled trial of local analgesia in laparoscopy
    Einarsson, JI
    Sun, J
    Tarrant, T
    Young, AE
    [J]. OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 21S - 21S
  • [30] Creatine Supplementation in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alves, Christiano R. R.
    Santiago, Bianca M.
    Lima, Fernanda R.
    Otaduy, Maria C. G.
    Calich, Ana Luisa
    Tritto, Aline C. C.
    de Sa Pinto, Ana Lucia
    Roschel, Hamilton
    Leite, Claudia C.
    Benatti, Fabiana B.
    Bonfa, Eloisa
    Gualano, Bruno
    [J]. ARTHRITIS CARE & RESEARCH, 2013, 65 (09) : 1449 - 1459